Prostaglandins, leukotrienes, and essential fatty acids最新文献

{"title":"The biological actions of prostanoids in adipose tissue in physiological and pathophysiological conditions","authors":"Erkan Civelek,&nbsp;Gulsev Ozen","doi":"10.1016/j.plefa.2022.102508","DOIUrl":"10.1016/j.plefa.2022.102508","url":null,"abstract":"<div><p>Adipose tissue has been established as an endocrine organ that plays an important role in maintaining metabolic homeostasis. Adipose tissue releases several bioactive molecules called adipokines. Inflammation, dysregulation of adipokine synthesis, and secretion are observed in obesity and related diseases and cause adipose tissue dysfunction. Prostanoids, belonging to the eicosanoid family of lipid mediators, can be synthesized in adipose tissue and play a critical role in adipose tissue biology. In this review, we summarized the current knowledge regarding the interaction of prostanoids with adipokines, the expression of prostanoid receptors, and prostanoid synthase enzymes in adipose tissues in health and disease. Furthermore, the involvement of prostanoids in the physiological function or dysfunction of adipose tissue including inflammation, lipolysis, adipogenesis, thermogenesis, browning of adipocytes, and vascular tone regulation was also discussed by examining studies using pharmacological approaches or genetically modified animals for prostanoid receptors/synthase enzymes. Overall, the present review provides a perspective on the evidence from literature regarding the biological effects of prostanoids in adipose tissue. Among prostanoids, prostaglandin E2 (PGE₂) is prominent in regards to its substantial role in both adipose tissue physiology and pathophysiology. Targeting prostanoids may serve as a potential therapeutic strategy for preventing or treating obesity and related diseases.</p></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10440546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Breastmilk PUFA strongly associated with maternal dietary intake but not anthropometric parameters and breastmilk carotenoids","authors":"M.A. Zielinska-Pukos ,&nbsp;J. Bryś ,&nbsp;A. Wesolowska ,&nbsp;J. Hamulka","doi":"10.1016/j.plefa.2022.102505","DOIUrl":"10.1016/j.plefa.2022.102505","url":null,"abstract":"<div><h3>Background</h3><p>Long chain polyunsaturated fatty acids (PUFA) and the optimal n-6/n-3 fatty acids ratio are essential for proper neurodevelopment in infancy. This study aimed to evaluate the association between breastmilk fatty acid intake and maternal dietary intake, anthropometrics and breastmilk carotenoid levels.</p></div><div><h3>Methods</h3><p>This observational, prospective study included 44 women in the first, third, and sixth month of lactation. At each study visit, maternal anthropometric measures were assessed and breastmilk samples were collected and assessed for fatty acids and carotenoids. At the third and sixth month, maternal diet was evaluated by three-day foods record.</p></div><div><h3>Results</h3><p>Mean breastmilk docosahexaenoic (DHA) was 0.58%, 0.47%, and 0.49%, respectively at the 1, 3, and 6 month (<em>p</em> ≤ 0.05). Mean DHA intake were higher in month 3 compared to 6: 357 vs. 169 mg/day. Pre-pregnancy BMI was associated with SFA, PUFA, and n-6 PUFA at 1 month, whereas current BMI to SFA at months 1 and 3. DHA was correlated with lycopene, total carotenoids at 1 month and total carotenoids at month 3, whereas n-3 PUFA to lycopene at 1 month. DHA, n-3 PUFA, n-6 PUFA and saturated (SFA) levels were associated with its dietary intake both at months 3 and 6, AA/DHA and LA/ALA ratios only at month 3.</p></div><div><h3>Conclusions</h3><p>Maternal intake of PUFA and n-6/n-3 ratios were a good predictor of its breastmilk composition, whereas pre-pregnancy and current BMI, as well as breastmilk carotenoids had a limited influence.</p></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10442411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A high sucrose diet modifies brain oxylipins in a sex-dependent manner","authors":"Jennifer E. Norman ,&nbsp;Saivageethi Nuthikattu ,&nbsp;Dragan Milenkovic ,&nbsp;John C. Rutledge ,&nbsp;Amparo C. Villablanca","doi":"10.1016/j.plefa.2022.102506","DOIUrl":"10.1016/j.plefa.2022.102506","url":null,"abstract":"<div><h3>Background</h3><p>Oxylipins have been implicated in many biological processes and diseases. Dysregulation of cerebral lipid homeostasis and altered lipid metabolites have been associated with the onset and progression of dementia. Although most dietary interventions have focused on modulation of dietary fats, the impact of a high sucrose diet on the brain oxylipin profile is unknown.</p></div><div><h3>Methods</h3><p>Male and female C57BL/6J mice were fed a high sucrose diet (HSD, 34%) in comparison to a control low sucrose diet (LSD, 12%) for 12 weeks beginning at 20 weeks of age. The profile of 53 free oxylipins was then measured in brain by ultra-high performance liquid chromatography tandem mass spectrometry. Serum glucose and insulin were measured enzymatically. We first assessed whether there were any effects of the diet on the brain oxylipin profile, then assessed for sex differences.</p></div><div><h3>Results</h3><p>There were no differences in fasting serum glucose between the sexes for mice fed a HSD or in fasting serum insulin levels for mice on either diet. The HSD altered the brain oxylipin profile in both sexes in distinctly different patterns: there was a reduction in three oxylipins (by 47–61%) and an increase in one oxylipin (16%) all downstream of lipoxygenase enzymes in males and a reduction in eight oxylipins (by 14–94%) mostly downstream of cyclooxygenase activity in females. 9-oxo-ODE and 6-trans-LTB4 were most influential in the separation of the oxylipin profiles by diet in male mice, whereas 5-HEPE and 12-HEPE were most influential in the separation by diet in female mice. Oxylipins 9‑hydroxy-eicosatetraenoic acid (HETE), 11-HETE, and 15-HETE were higher in the brains of females, regardless of diet.</p></div><div><h3>Conclusion</h3><p>A HSD substantially changes brain oxylipins in a distinctly sexually dimorphic manner. Results are discussed in terms of potential mechanisms and links to metabolic disease. Sex and diet effects on brain oxylipin composition may provide future targets for the management of neuroinflammatory diseases, such as dementia.</p></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0952327822001181/pdfft?md5=177d2356082d2f455bab6c1d674dd503&pid=1-s2.0-S0952327822001181-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10432394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Increases in plasma n-3 tetracosapentaenoic acid and tetracosahexaenoic acid following 12 weeks of EPA, but not DHA, supplementation in women and men","authors":"Ruxandra D. Rotarescu ,&nbsp;Kimia Rezaei ,&nbsp;David M. Mutch ,&nbsp;Adam H. Metherel","doi":"10.1016/j.plefa.2022.102494","DOIUrl":"10.1016/j.plefa.2022.102494","url":null,"abstract":"<div><p>Dietary feeding and stable isotope studies in rodents support that the 24-carbon omega-3 polyunsaturated fatty acids, tetracosapentaenoic acid (24:5n-3, TPAn-3) and tetracosahexaenoic acid (24:6n-3, THA), are immediate precursors to docosahexaenoic acid (DHA, 22:6n-3). In this study, we assessed for the first time, changes in TPAn-3 or THA levels following omega-3 PUFA supplementation in humans, providing insight into human omega-3 PUFA metabolism. In this secondary analysis of a double-blind randomized control trial, women and men (19 – 30 years, <em>n</em> = 10 – 14 per sex, per diet) were supplemented with 3 g/day EPA, DHA, or olive oil control for 12 weeks. Plasma TPAn-3 and THA concentrations were determined by gas chromatography-mass spectrometry to determine changes following supplementation in a sex-specific manner (sex <em>x</em> time). EPA supplementation significantly increased (<em>p</em> &lt; 0.0001) plasma TPAn-3 by 215% (1.3 ± 0.1 – 4.1 ± 0.7, nmol/mL ± SEM) and THA by 112% (1.7 ± 0.2 – 3.6 ± 0.5, nmol/mL ± SEM). Furthermore, women had 111% and 99% higher plasma TPAn-3 and THA in the EPA supplemented group compared to men (<em>p</em> &lt; 0.0001). There were no significant effects of time on plasma TPAn-3 or THA concentrations in the DHA supplemented or olive oil supplemented groups. In conclusion, EPA, but not DHA, supplementation in humans increased plasma TPAn-3 and THA levels, suggesting that THA accumulates prior to conversion to DHA in the n-3 PUFA synthesis pathway. Furthermore, women generally exhibit higher plasma TPAn-3 and THA concentrations compared with men, suggesting that women have a greater ability to accumulate 24-carbon n-3 PUFA in plasma via EPA and DPAn-3 elongation, which may explain the known higher DHA levels in women.</p><p>Summary: In this secondary analysis of a double-blind randomized control trial, we assessed changes in omega-3 (n-3) tetracosapentaenoic acid (24:5n-3, TPAn-3) and tetracosahexaenoic acid (24:6n-3, THA) plasma levels in women and men (19 – 30 years, <em>n</em> = 10 – 14 per sex, per diet) following 12-weeks of n-3 PUFA supplementation (3 g/day EPA, DHA or olive oil). Women had higher plasma TPAn-3 in all supplementation groups and higher THA levels in the EPA and olive oil groups (<em>p</em> &lt; 0.0001) compared to men. EPA supplementation increased (<em>p</em> &lt; 0.0001) plasma TPAn-3 by 215% (1.3 ± 0.1 – 4.1 ± 0.7, nmol/mL ± SEM) and THA by 112% (1.7 ± 0.2 – 3.6 ± 0.5, nmol/mL ± SEM), but DHA supplementation had no effect. For the first time in humans, we show that plasma TPAn-3 and THA levels are higher in women and increased with EPA, but not DHA supplementation, suggesting an accumulation of THA prior to conversion to DHA in the n-3 PUFA synthesis pathway.</p></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10440519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to ‘Metabolic syndrome in postmenopausal women is associated with lower erythrocyte PUFA/MUFA and n-3/n-6 ratio: A case-control study’[Prostaglandins Leukot Essent Fatty Acids. 2020 Aug;159:102155.]","authors":"Agata Muzsik ,&nbsp;Henryk H Jeleń ,&nbsp;Agata Chmurzynska","doi":"10.1016/j.plefa.2022.102436","DOIUrl":"10.1016/j.plefa.2022.102436","url":null,"abstract":"","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0952327822000485/pdfft?md5=9f8dbf6a623dbbc5f0300be014c865aa&pid=1-s2.0-S0952327822000485-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89468849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of placental fatty acid desaturase 2 (FADS2) methylation with maternal fatty acid levels in women with preeclampsia","authors":"Kinjal Dave ,&nbsp;Lovejeet Kaur ,&nbsp;Deepali Sundrani ,&nbsp;Preeti Sharma ,&nbsp;Swati Bayyana ,&nbsp;Savita Mehendale ,&nbsp;Karuna Randhir ,&nbsp;Giriraj R Chandak ,&nbsp;Sadhana Joshi","doi":"10.1016/j.plefa.2022.102472","DOIUrl":"10.1016/j.plefa.2022.102472","url":null,"abstract":"<div><h3>Introduction</h3><p>Biosynthesis of long-chain polyunsaturated fatty acids requires sequential activities of desaturases and elongases for conversion of fatty acid precursors to products. The delta-6 desaturase enzyme, encoded by <em>FADS2</em> gene, is a rate limiting enzyme in this pathway. Alterations in D6D enzyme activity can lead to altered fatty acid profiles.</p></div><div><h3>Objectives</h3><p>To examine differences in placental DNA methylation (DNAm) and expression of <em>FADS2</em> gene in preeclampsia women compared to normal women and their association with maternal variables (plasma fatty acids, desaturase enzyme index, blood pressure), placental weight and birth outcomes.</p></div><div><h3>Methods</h3><p>DNAm and expression of <em>FADS2</em> gene were examined in placentae of normotensive (<em>n</em> = 100) control and preeclampsia (<em>n</em> = 100) women using pyrosequencing and quantitative real-time PCR respectively. Women with preeclampsia included those delivering at term (<em>n</em> = 43, gestation ≥ 37 weeks; T-PE) or preterm (<em>n</em> = 57, gestation &lt; 37 weeks; PT-PE). A total of 26 CpGs in <em>FADS2</em> promoter and region around it, were analysed in two PCR reactions (region 1 and 2).</p></div><div><h3>Results</h3><p>Out of 13 CpGs in region 1, significant hypermethylation was noted at CpG3 in T-PE (<em>p</em> = 0.03) and of 13 CpGs in region 2, CpG2 (<em>p</em> = 0.008), CpG11 (<em>p</em> = 0.04), CpG12 (<em>p</em> = 0.001) were hypomethylated and CpG13 (<em>p</em> = 0.001) was hypermethylated in preeclampsia group, as compared to controls. <em>FADS2</em> expression was lower in PT-PE as compared to controls (<em>p</em> = 0.04). DNAm at various CpGs in the <em>FADS2</em> were associated with maternal plasma FADS2 enzyme index and also associated with maternal fatty acid levels. However, we did not observe any association of DNAm with maternal blood pressure, placental weight and birth outcomes.</p></div><div><h3>Conclusions</h3><p>This study for the first time reports differential methylation of <em>FADS2</em> and its association with impaired maternal fatty acid metabolism in preeclampsia and provides a mechanistic basis to our earlier observations of altered maternal LCPUFA levels in women with preeclampsia.</p></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10441830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Circulating polyunsaturated fatty acids, pressure pain thresholds, and nociplastic pain conditions","authors":"Anne E. Sanders ,&nbsp;E. Diane Weatherspoon ,&nbsp;Brandie M. Ehrmann ,&nbsp;Paul S. Soma ,&nbsp;Saame R. Shaikh ,&nbsp;John S. Preisser ,&nbsp;Richard Ohrbach ,&nbsp;Roger B. Fillingim ,&nbsp;Gary D. Slade","doi":"10.1016/j.plefa.2022.102476","DOIUrl":"10.1016/j.plefa.2022.102476","url":null,"abstract":"<div><h3>Objective</h3><p>Polyunsaturated fatty acids (PUFAs) play a role in pain regulation. This study sought to determine whether free PUFAs found in red blood cells also play a role in nociceptive processing. We examined associations between circulating PUFAs and nociceptive thresholds to noxious mechanical stimuli. We also determined whether nociceptive thresholds were associated with nociplastic pain conditions.</p></div><div><h3>Methods</h3><p>This cross-sectional study used stored red bloods cells and data from 605 adult participants in the OPPERA-2 study of chronic overlapping pain conditions. In OPPERA-2 adults completed quantitative sensory testing in which pressure algometry measured deep muscular tissue sensitivity at six anatomical sites. Standardized protocols classified adults for presence or absence of five nociplastic pain conditions: temporomandibular disorder, headache, low back pain, irritable bowel syndrome and fibromyalgia. Liquid chromatography tandem mass spectroscopy quantified erythrocyte PUFAs. We conducted three sets of analyses. First, a multivariable linear regression model assessed the association between n-6/n-3 PUFA ratio and the number of overlapping nociplastic pain conditions. Second, a series of 36 multivariable linear regression models assessed covariate-adjusted associations between PUFAs and nociceptive thresholds at each of six anatomical sites. Third, a series of 30 multivariable linear regression models assessed covariate-adjusted associations between nociceptive thresholds at six anatomical sites and each of five pain conditions.</p></div><div><h3>Results</h3><p>In multiple linear regression, each unit increase in n-6/n-3 PUFA ratio was associated with more pain conditions (<em>β</em> = 0.30, 95% confidence limits: 0.07, 0.53, <em>p</em> = 0.012). Omega-6 linoleic acid and arachidonic acid were negatively associated with lower nociceptive thresholds at three and at five, respectively, anatomical sites. In contrast, omega-3 alpha-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid and the n-6/n-3 PUFA ratio were not associated with nociceptive thresholds at any site. Pain cases had significantly lower nociceptive thresholds than non-case controls at all anatomical sites.</p></div><div><h3>Conclusion</h3><p>A higher n-6/n-3 PUFA ratio was associated with more pain conditions. Omega-6 PUFAs may promote a generalized upregulation of nociceptive processing.</p></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9907477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis","authors":"Axel Nordström ,&nbsp;Mattias Jangard ,&nbsp;Marie Svedberg ,&nbsp;Michael Ryott ,&nbsp;Maria Kumlin","doi":"10.1016/j.plefa.2022.102474","DOIUrl":"10.1016/j.plefa.2022.102474","url":null,"abstract":"<div><p>Severe nasal polyposis and mucosal inflammation, in patients with chronic rhinosinusitis (CRS) may include a dysregulated eicosanoid profile, but a clinical role for eicosanoids in CRS with nasal polyps (NP; CRSwNP) remains to be elucidated. This study focused on assessing levels and clinical implications of inflammatory mediators in nasal secretions and urine from patients with different NP severity or Aspirin Exacerbated Respiratory Disease (AERD). Levels of leukotrienes E₄ and B₄, prostaglandins D₂ and E₂ as well as 15(<em>S</em>)-hydroxyeicosatetraenoic acid were measured with enzyme immunoassays and cytokines with magnetic bead immunoassays. Patients with CRSwNP were subdivided based on NP score; CRSwNP-low (NP score ≤ 4, <em>n</em> = 11) or CRSwNP-high (NP score ≥ 5, <em>n</em> = 32) and compared to CRS without polyps (CRSsNP, <em>n</em> = 12), CRSwNP-AERD (<em>n</em> = 11) and individuals without CRS (<em>n</em> = 25). Smell test score, fractional exhaled nitric oxide (FeNO), blood eosinophils and Sinonasal outcome test-22 were assessed as clinical markers. Leukotriene E₄, prostaglandin D₂ and 15(<em>S</em>)-hydroxyeicosatetraenoic acid in nasal secretions correlated with NP score. Nasal leukotriene E₄ also correlated with FeNO and smell test score, with highest levels found in CRSwNP-AERD. Levels of prostaglandin D₂ in nasal secretion as well as urinary levels of the prostaglandin D₂ metabolite 11β-prostaglandin F_2α differed between CRSNP-high and CRSwNP-low. Urinary 11β-prostaglandin F_2α was associated with asthma comorbidity whereas a similar association with prostaglandin D₂ in nasal secretions was not observed. In conclusion, subdividing patients based on NP severity in combination with analysis of eicosanoids in non-invasively collected nasal secretions, may have clinical implications when assessing CRS disease severity.</p></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0952327822000862/pdfft?md5=254b257f03d1d87fad46433e4c7cdbdc&pid=1-s2.0-S0952327822000862-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10431388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effect of α-linolenic acid enrichment in perinatal diets in preventing high fat diet-induced SCD1 increased activity and lipid disarray in adult offspring of low density lipoprotein receptor knockout (LDLRKO) mice","authors":"A. Leikin-Frenkel ,&nbsp;H. Cohen ,&nbsp;R. Keshet ,&nbsp;R. Shnerb-GanOr ,&nbsp;M. Kandel-Kfir ,&nbsp;A. Harari ,&nbsp;K.S. Hollander ,&nbsp;A. Shaish ,&nbsp;D. Harats ,&nbsp;Y. Kamari","doi":"10.1016/j.plefa.2022.102475","DOIUrl":"10.1016/j.plefa.2022.102475","url":null,"abstract":"<div><p>The present study examined the effects of maternal perinatal dietary ALA enrichment on the high fat diet (HFD)-induced lipid disarray in the adult offspring of low density lipoprotein receptor knock-out (LDLRKO) mice.</p><p><span>Female LDLRKO mice received, during pregnancy and lactation, isocaloric diets with either corn oil, </span><strong>RD</strong>, or flax oil, <strong>ALA</strong><span>. The weaning offspring was given a regular chow diet for a washout period of eight weeks, which was followed by HFD for eight weeks. Plasma and liver lipids and SCD1 activity were then analyzed.</span></p><p>The HFD-fed RD adult offspring had substantially higher plasma cholesterol levels than the HFD-fed ALA offspring (15.7 versus 9.7 mmole/l, <em>p</em>&lt;0.00001) and non-alcoholic fatty liver disease (NAFLD) (65.0 versus 23.9 mg/g lipids, <em>p</em>&lt;0.00001). Liver lipids oleic acid (OA) content and monounsaturated to saturated fatty acids (MUFA/SAT) ratio, were two times lower in RD compared to ALA (<em>p</em>&lt;0.0001). The threefold HFD-induced SCD1 raised activity (<em>p</em>&lt;0.00001), and OA produced from SA, observed in RD adult offspring were prevented by perinatal ALA.</p><p>In conclusion, the resilience of SCD1 to HFD- induced increased activity may account for the beneficial effects of perinatal ALA dietary enrichment in preventing NAFLD and hypercholesterolemia from occurring in adult LDLRKO offspring mice.</p></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10499152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Profiling of lipid mediators in atherosclerotic carotid plaques from type 2 diabetic and non-diabetic patients.","authors":"Louise Ménégaut ,&nbsp;Aline Laubriet ,&nbsp;Valentin Crespy ,&nbsp;Maxime Nguyen ,&nbsp;Jean-Michel Petit ,&nbsp;Georges Tarris ,&nbsp;Thomas Pilot ,&nbsp;Alexis Varin ,&nbsp;Hélène Choubley ,&nbsp;Victoria Bergas ,&nbsp;Jean-Paul Pais de Barros ,&nbsp;Charles Thomas ,&nbsp;Eric Steinmetz ,&nbsp;David Masson","doi":"10.1016/j.plefa.2022.102477","DOIUrl":"10.1016/j.plefa.2022.102477","url":null,"abstract":"<div><h3>Background and aims</h3><p>Diabetes is associated with an accelerated development of atherosclerosis. Specific mechanisms related to diabetes and hyperglycemia may play a role in this process. In particular, alterations of arachidonic acid (AA) metabolism have been reported. Our main goal was to investigate for differences in the concentration of LTB4 and RvD1 as well as selected cyclooxygenase-derived mediators in carotid plaques from diabetic and non-diabetic patients. We also aimed to analyze the relationship between omega 6 and omega 3 Poly-Unsaturated Fatty acids (PUFAs) content in the plaques and the concentrations of these lipid mediators.</p></div><div><h3>Methods</h3><p>29 type 2 diabetic patients and 30 control patients admitted for surgical treatment of carotid stenosis were enrolled in the present study. Carotid plaques were harvested for in-depth lipidomic profiling.</p></div><div><h3>Results</h3><p>No differences for LTB4 or other lipid mediators were observed between diabetic and non-diabetic patients. RvD1 levels were below the threshold of quantification in most of the samples. A significant correlation was found between LTB4 and 5(<em>S</em>)-HETE levels. Omega 3 enrichment was not significantly different between control and diabetic plaques. There was a negative correlation between DHA/AA ratio and the level of 5(<em>S</em>)-HETE while there was a positive association with TXB2 and PGD2 concentrations.</p></div><div><h3>Conclusion-perspectives</h3><p>Our results does not support the hypothesis of a specific involvement of LTB4 or COX-derived mediators in diabetic atherosclerosis. The relationship between DHA enrichment and the concentrations of specific inflammatory mediators within the plaque is of interest and will need to be confirmed in larger studies.</p></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10446407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}